In conclusion, these results demonstrate that PSD-95-processing is an early mechanism of regulation, not only induced by in vitro excitotoxicity but also in brain ischemia, where excitotoxicity takes place in vivo. The gene discussed is DLG4; the disease is brain ischemia.